Navigation Links
US Oncology Commends Governor Sebelius' Confirmation as U.S. Secretary of Health and Human Services
Date:4/28/2009

Kansas Governor a Strong Choice Due to Experience in Navigating Complex Health Care Access Issues, Working Across Party Lines to Promote Reform

WASHINGTON, April 28 /PRNewswire-USNewswire/ -- US Oncology, which supports one of the nation's largest cancer treatment and research networks representing approximately 1,200 oncologists nationwide, applauds today's Senate confirmation of Kansas Governor Kathleen Sebelius as U.S. Secretary of Health and Human Services (HHS).

"US Oncology is pleased to see Secretary Sebelius take the helm of national health care reform and push for new methods to address the current obstacles restricting access to quality health care for all -- particularly for the more than 10 million Americans now living with cancer," said Roy Beveridge, M.D., Chairman of the US Oncology Public Policy Steering Committee. "We look forward to working closely with Sec. Sebelius and her colleagues to create practical, enduring solutions that address our system challenges while always first advancing the needs of America's cancer patients."

Prior to her appointment as Secretary, Gov. Sebelius established a record of working in a bipartisan manner to promote health care reform during her eight years as Governor and six years as Kansas' insurance commissioner, and helped draft a national patients' bill of rights during her work as commissioner. As HHS Secretary, she will lead the federal government's largest domestic department, overseeing the Centers for Medicare and Medicaid Services (CMS), the Food and Drug Administration (FDA), the National Institutes of Health (NIH) and other key health care decision-making agencies.

"Secretary Sebelius will play a chief role in promoting the advancement of sweeping reform measures and technological innovations designed to improve care delivery while lowering costs, such as President Obama's priority to expand the use of health information technology and electronic medical records (EMRs)," added Dr. Beveridge. "US Oncology's extensive iKnowMed oncology-specific EMR system has led to major care improvements and enhanced patient outcomes, and we hope to work with Sec. Sebelius to apply similar strategies designed to improve the patient and physician experience across all areas of care."

About US Oncology, Inc.

Headquartered in Houston, US Oncology works closely with physicians, manufacturers and payers to enhance patient access to advanced cancer care in the community setting. US Oncology supports the nation's foremost cancer treatment and research network in its efforts to accelerate the availability and use of scientific, evidence-based medicine.

According to the company's last quarterly earnings report, US Oncology is affiliated with more than 1,200 physicians operating in approximately 485 locations, including 92 cancer centers and radiation facilities in 39 states. For more information, visit the company's Web site, www.usoncology.com.


'/>"/>
SOURCE US Oncology
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Compendia Bioscience Announces Collaboration with MDS Pharma Services to Deliver Novel Solution for Oncology Drug Development
2. Pharmatech Oncology Launches New Data Management Business Unit
3. Poniard Announces Publication of Results of Picoplatin Phase 2 Study in Journal of Clinical Oncology
4. Pathwork Tissue of Origin Test Validation Study Published in Journal of Clinical Oncology
5. US Oncology Wins Three National Safety Council Awards
6. Medarex Highlights Oncology Pipeline at Needham Cancer Therapeutics Conference in New York City
7. Poniard Pharmaceuticals to Focus Company Resources on Late-Stage Oncology Candidate Picoplatin Through Realignment of Research Organization
8. Radiation Oncology Institute (ROI) Campaign Raises $7 Million
9. House Bill to Improve Accuracy of Medicare Reimbursement Introduced: Members of Congress Seek to Stem Growing Healthcare Coverage Shortfalls, Community Oncology Alliance Advocates for Swift Passage of Bill
10. ACORNs Success in Delivering Top Quality Research Portfolio to Community-Based Oncology Practices Presented at Annual Investigator Meeting
11. US Oncology Reports Fourth Quarter and Yearend 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... ... May 02, 2016 , ... Dr. Jonathan Kulbersh of Carolina Facial Plastics isn’t surprised ... five on the list of “ 5 US Cities with the Highest Plastic Rates .” ... and Miami. The results were calculated using a survey by RealSelf and ...
(Date:5/2/2016)... ... May 02, 2016 , ... MedaCheck, a leading medication ... outcomes, has announced its partnership with GrandView Health Services. , With decades of ... counter and prescription drug pharmacy services to thousands of residents. Serving Indiana, Ohio, ...
(Date:5/2/2016)... ... May 02, 2016 , ... The Evolve Paddle Board Company- which specializes ... today the outcome of their partnership with Yoloha Yoga- producers of high quality cork ... , SUP yoga has seen a dramatic rise in popularity throughout the last few ...
(Date:5/2/2016)... ... May 02, 2016 , ... One of Hollywood’s best kept ... Dermatology Surgery & Laser Center, in Milford, Penn. “Patients with busy lives want noninvasive ... fat treated and go home or back to work without having to wear recovery ...
(Date:5/2/2016)... Worcester, MA and Shelton, CT (PRWEB) , ... May 02, 2016 ... ... Scott Krug, President and Owner of New England Low Vision and Blindness (NELV&B) ... location will add more flexibility and convenience for people with vision impairments to get ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 28, 2016 , Net Sales of $1.90 ... over the prior year period, and an increase of 1.2% ... Diluted EPS for the first quarter were $0.52 reported, a ... adjusted, an increase of 29.9% over the prior year period ... earnings guidance for 2016 Zimmer Biomet Holdings, Inc. ...
(Date:4/28/2016)... Florida , April 28, 2016 ... the development of innovative peptide and gene-based immunotherapeutics and vaccines ... it will be presenting at the 3rd Annual Growth ... - 5 th , 2016 at Caesars Palace in Las Vegas, ... 8.00 am on Wednesday, May 4 th by Dr. ...
(Date:4/27/2016)... 27, 2016   ... in Recurring Consumable Sales  Clinical sales grow ... Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the ... for the first quarter ended March 31, 2016 and ... of its commercial strategy. First Quarter 2016 ...
Breaking Medicine Technology: